These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31361020)

  • 41. The neuropsychological profiles of young psychosis patients with and without current cannabis use.
    Bogaty SER; Crouse JJ; Hickie IB; Hermens DF
    Cogn Neuropsychiatry; 2019 Jan; 24(1):40-53. PubMed ID: 30621505
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Schizophrenia and the Environment: Within-Person Analyses May be Required to Yield Evidence of Unconfounded and Causal Association-The Example of Cannabis and Psychosis.
    van Os J; Pries LK; Ten Have M; de Graaf R; van Dorsselaer S; Bak M; Wittchen HU; Rutten BPF; Guloksuz S
    Schizophr Bull; 2021 Apr; 47(3):594-603. PubMed ID: 33693921
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Self-reported quality of life in a Scottish first-episode psychosis cohort: associations with symptomatology and premorbid adjustment.
    MacBeth A; Gumley A; Schwannauer M; Fisher R
    Early Interv Psychiatry; 2015 Feb; 9(1):53-60. PubMed ID: 24034336
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Marijuana use in the immediate 5-year premorbid period is associated with increased risk of onset of schizophrenia and related psychotic disorders.
    Kelley ME; Wan CR; Broussard B; Crisafio A; Cristofaro S; Johnson S; Reed TA; Amar P; Kaslow NJ; Walker EF; Compton MT
    Schizophr Res; 2016 Mar; 171(1-3):62-7. PubMed ID: 26785806
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cannabis use related to early psychotic onset: Role of premorbid function.
    Frascarelli M; Quartini A; Tomassini L; Russo P; Zullo D; Manuali G; De Filippis S; Bersani G
    Neurosci Lett; 2016 Oct; 633():55-61. PubMed ID: 27637389
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study.
    Di Forti M; Marconi A; Carra E; Fraietta S; Trotta A; Bonomo M; Bianconi F; Gardner-Sood P; O'Connor J; Russo M; Stilo SA; Marques TR; Mondelli V; Dazzan P; Pariante C; David AS; Gaughran F; Atakan Z; Iyegbe C; Powell J; Morgan C; Lynskey M; Murray RM
    Lancet Psychiatry; 2015 Mar; 2(3):233-8. PubMed ID: 26359901
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reflection impulsivity and response inhibition in first-episode psychosis: relationship to cannabis use.
    Huddy VC; Clark L; Harrison I; Ron MA; Moutoussis M; Barnes TR; Joyce EM
    Psychol Med; 2013 Oct; 43(10):2097-107. PubMed ID: 23339857
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systemic inflammation and intelligence in early adulthood and subsequent risk of schizophrenia and other non-affective psychoses: a longitudinal cohort and co-relative study.
    Kappelmann N; Khandaker GM; Dal H; Stochl J; Kosidou K; Jones PB; Dalman C; Karlsson H
    Psychol Med; 2019 Jan; 49(2):295-302. PubMed ID: 29622048
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cannabis use and psychosis: a review of reviews.
    Hasan A; von Keller R; Friemel CM; Hall W; Schneider M; Koethe D; Leweke FM; Strube W; Hoch E
    Eur Arch Psychiatry Clin Neurosci; 2020 Jun; 270(4):403-412. PubMed ID: 31563981
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings.
    Meijer JH; Dekker N; Koeter MW; Quee PJ; van Beveren NJ; Meijer CJ;
    Psychol Med; 2012 Apr; 42(4):705-16. PubMed ID: 21899795
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of duration of untreated psychosis and premorbid intelligence on cognitive functioning in patients with first-episode schizophrenia.
    Wang MY; Ho NF; Sum MY; Collinson SL; Sim K
    Schizophr Res; 2016 Aug; 175(1-3):97-102. PubMed ID: 27146474
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cognitive reserve as a moderator of outcomes in five clusters of first episode psychosis patients: a 10-year follow-up study of the PAFIP cohort.
    Ayesa-Arriola R; de la Foz VO; Murillo-García N; Vázquez-Bourgon J; Juncal-Ruiz M; Gómez-Revuelta M; Suárez-Pinilla P; Setién-Suero E; Crespo-Facorro B
    Psychol Med; 2023 Apr; 53(5):1891-1905. PubMed ID: 37310335
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis.
    González-Blanco L; García-Portilla MP; Gutiérrez M; Mezquida G; Cuesta MJ; Urbiola E; Amoretti S; Barcones F; González-Pinto A; Pina-Camacho L; Corripio I; Vieta E; Baeza I; Toll A; Sáiz PA; Bobes J; Bernardo M;
    Schizophr Res; 2021 Oct; 236():19-28. PubMed ID: 34365082
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Social inclusion and its interrelationships with social cognition and social functioning in first-episode psychosis.
    Gardner A; Cotton SM; Allott K; Filia KM; Hester R; Killackey E
    Early Interv Psychiatry; 2019 Jun; 13(3):477-487. PubMed ID: 29076286
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of cognition, premorbid adjustment and psychotic symptoms on psycho-social functioning in first-episode psychosis.
    Grau N; Rubio-Abadal E; Usall J; Barajas A; Butjosa A; Dolz M; Baños I; Sánchez B; Rodríguez MJ; Peláez T; Sammut S; Carlson J; Huerta-Ramos E; ; Ochoa S
    Psychiatry Res; 2016 Aug; 242():157-162. PubMed ID: 27280526
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [What support of young presenting a first psychotic episode, when schooling is being challenged?].
    Vacheron MN; Veyrat-Masson H; Wehbe E
    Encephale; 2017 Dec; 43(6):570-576. PubMed ID: 29128195
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The relationship of symptom dimensions with premorbid adjustment and cognitive characteristics at first episode psychosis: Findings from the EU-GEI study.
    Ferraro L; La Cascia C; La Barbera D; Sanchez-Gutierrez T; Tripoli G; Seminerio F; Sartorio C; Marrazzo G; Sideli L; Arango C; Arrojo M; Bernardo M; Bobes J; Del-Ben CM; Gayer-Anderson C; Jongsma HE; Kirkbride JB; Lasalvia A; Tosato S; Llorca PM; Menezes PR; Rutten BP; Santos JL; Sanjuán J; Selten JP; Szöke A; Tarricone I; Muratori R; Tortelli A; Velthorst E; Rodriguez V; Quattrone A; Jones PB; Van Os J; Vassos E; Morgan C; de Haan L; Reininghaus U; Cardno AG; Di Forti M; Murray RM; Quattrone D
    Schizophr Res; 2021 Oct; 236():69-79. PubMed ID: 34403965
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Social functioning trajectories of young first-episode psychosis patients with and without cannabis misuse: a 30-month follow-up study.
    González-Blanch C; Gleeson JF; Koval P; Cotton SM; McGorry PD; Alvarez-Jimenez M
    PLoS One; 2015; 10(4):e0122404. PubMed ID: 25849623
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The relationship between cannabis use and cognition in people diagnosed with first-episode psychosis.
    de Vos C; Leopold K; Blanke ES; Siebert S; Baumgardt J; Burkhardt E; Bechdolf A
    Psychiatry Res; 2020 Nov; 293():113424. PubMed ID: 32862065
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Deficits of cognitive theory of mind and its relationship with functioning in individuals with an at-risk mental state and first-episode psychosis.
    Ohmuro N; Katsura M; Obara C; Kikuchi T; Sakuma A; Iizuka K; Hamaie Y; Ito F; Matsuoka H; Matsumoto K
    Psychiatry Res; 2016 Sep; 243():318-25. PubMed ID: 27434201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.